Areteia Therapeutics
Clinical trials sponsored by Areteia Therapeutics, explained in plain language.
-
Experimental asthma pill shows promise, but study halted early
Disease control TerminatedThis study tested an oral drug called dexpramipexole in over 1,000 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks when added to standard…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Asthma drug safety check ends early: what we know
Disease control TerminatedThis study aimed to check the long-term safety of the drug dexpramipexole in adults with severe eosinophilic asthma. It included 509 people who had already finished a previous phase 3 study. The trial was terminated early, so results are limited.
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Asthma drug trial halted midway: what happened?
Disease control TerminatedThis study tested a daily pill called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks. The trial was terminated ear…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:03 UTC